An	0	2	O
assay	3	8	O
to	9	11	O
measure	12	19	O
angiogenesis	20	32	O
in	33	35	O
human	36	41	B-Organism
fat	42	45	B-Tissue
tissue	46	52	I-Tissue
.	52	53	O

BACKGROUND	55	65	O
:	65	66	O
Inhibition	67	77	O
of	78	80	O
angiogenesis	81	93	O
reverses	94	102	O
rodent	103	109	O
obesity	110	117	O
.	117	118	O

A	119	120	O
validated	121	130	O
assay	131	136	O
in	137	139	O
human	140	145	B-Organism
fat	146	149	B-Tissue
tissue	150	156	I-Tissue
is	157	159	O
needed	160	166	O
to	167	169	O
study	170	175	O
the	176	179	O
role	180	184	O
of	185	187	O
angiogenesis	188	200	O
in	201	203	O
human	204	209	B-Organism
obesity	210	217	O
.	217	218	O

METHODS	219	226	O
:	226	227	O
Human	228	233	B-Organism
fat	234	237	B-Tissue
tissue	238	244	I-Tissue
fragments	245	254	O
from	255	259	O
surgery	260	267	O
were	268	272	O
placed	273	279	O
in	280	282	O
96	283	285	O
-	285	286	O
well	286	290	O
plates	291	297	O
,	297	298	O
embedded	299	307	O
in	308	310	O
fibrin	311	317	B-Gene_or_gene_product
thrombin	318	326	B-Gene_or_gene_product
clot	327	331	B-Organism_substance
and	332	335	O
overlaid	336	344	O
with	345	349	O
cell	350	354	B-Cell
culture	355	362	O
media	363	368	O
containing	369	379	O
20	380	382	O
%	382	383	O
fetal	384	389	O
bovine	390	396	B-Organism
serum	397	402	B-Organism_substance
.	402	403	O

After	404	409	O
15	410	412	O
days	413	417	O
,	417	418	O
the	419	422	O
clots	423	428	B-Organism_substance
were	429	433	O
examined	434	442	O
by	443	445	O
histology	446	455	O
and	456	459	O
electron	460	468	O
microscopy	469	479	O
.	479	480	O

The	481	484	O
effect	485	491	O
of	492	494	O
taxol	495	500	B-Drug_or_compound
,	500	501	O
cobalt	502	508	B-Drug_or_compound
chloride	509	517	I-Drug_or_compound
and	518	521	O
a	522	523	O
heparin	524	531	B-Drug_or_compound
-	531	532	I-Drug_or_compound
steroid	532	539	I-Drug_or_compound
combination	540	551	O
was	552	555	O
tested	556	562	O
in	563	565	O
the	566	569	O
fat	570	573	B-Tissue
tissue	574	580	I-Tissue
assay	581	586	O
and	587	590	O
compared	591	599	O
to	600	602	O
the	603	606	O
validated	607	616	O
human	617	622	B-Organism
placental	623	632	B-Multi-tissue_structure
vein	633	637	I-Multi-tissue_structure
angiogenesis	638	650	O
model	651	656	O
(	657	658	O
HPVAM	658	663	O
)	663	664	O
.	664	665	O

RESULTS	666	673	O
:	673	674	O
Blood	675	680	B-Multi-tissue_structure
vessels	681	688	I-Multi-tissue_structure
initiated	689	698	O
growth	699	705	O
and	706	709	O
elongated	710	719	O
from	720	724	O
the	725	728	O
fat	729	732	B-Tissue
tissue	733	739	I-Tissue
fragments	740	749	O
over	750	754	O
15	755	757	O
days	758	762	O
.	762	763	O

Presence	764	772	O
of	773	775	O
blood	776	781	B-Multi-tissue_structure
vessels	782	789	I-Multi-tissue_structure
was	790	793	O
confirmed	794	803	O
with	804	808	O
histology	809	818	O
and	819	822	O
electron	823	831	O
microscopy	832	842	O
.	842	843	O

Taxol	844	849	B-Drug_or_compound
at	850	852	O
10	853	855	O
(	855	856	O
-	856	857	O
6	857	858	O
)	858	859	O
and	860	863	O
10	864	866	O
(	866	867	O
-	867	868	O
7	868	869	O
)	869	870	O
M	871	872	O
completely	873	883	O
inhibited	884	893	O
angiogenesis	894	906	O
,	906	907	O
while	908	913	O
Taxol	914	919	B-Drug_or_compound
10	920	922	O
(	922	923	O
-	923	924	O
8	924	925	O
)	925	926	O
and	927	930	O
10	931	933	O
(	933	934	O
-	934	935	O
9	935	936	O
)	936	937	O
M	938	939	O
and	940	943	O
the	944	947	O
heparin	948	955	B-Drug_or_compound
-	955	956	I-Drug_or_compound
steroid	956	963	I-Drug_or_compound
partially	964	973	O
inhibited	974	983	O
angiogenesis	984	996	O
.	996	997	O

The	998	1001	O
response	1002	1010	O
to	1011	1013	O
taxol	1014	1019	B-Drug_or_compound
and	1020	1023	O
heparin	1024	1031	B-Drug_or_compound
-	1031	1032	I-Drug_or_compound
steroid	1032	1039	I-Drug_or_compound
was	1040	1043	O
similar	1044	1051	O
to	1052	1054	O
that	1055	1059	O
of	1060	1062	O
the	1063	1066	O
HPVAM	1067	1072	O
,	1072	1073	O
a	1074	1075	O
validated	1076	1085	O
angiogenesis	1086	1098	O
assay	1099	1104	O
.	1104	1105	O

Cobalt	1106	1112	B-Drug_or_compound
chloride	1113	1121	I-Drug_or_compound
,	1121	1122	O
a	1123	1124	O
stimulator	1125	1135	O
of	1136	1138	O
vascular	1139	1147	B-Gene_or_gene_product
endothelial	1148	1159	I-Gene_or_gene_product
growth	1160	1166	I-Gene_or_gene_product
factor	1167	1173	I-Gene_or_gene_product
(	1174	1175	O
VEGF	1175	1179	B-Gene_or_gene_product
)	1179	1180	O
stimulated	1181	1191	O
angiogenesis	1192	1204	O
initiation	1205	1215	O
at	1216	1218	O
10	1219	1221	O
(	1221	1222	O
-	1222	1223	O
9	1223	1224	O
)	1224	1225	O
M	1226	1227	O
in	1228	1230	O
fat	1231	1234	B-Tissue
tissue	1235	1241	I-Tissue
and	1242	1245	O
the	1246	1249	O
HPVAM	1250	1255	O
,	1255	1256	O
but	1257	1260	O
at	1261	1263	O
10	1264	1266	O
(	1266	1267	O
-	1267	1268	O
10	1268	1270	O
)	1270	1271	O
M	1272	1273	O
blood	1274	1279	B-Multi-tissue_structure
vessel	1280	1286	I-Multi-tissue_structure
growth	1287	1293	O
was	1294	1297	O
stimulated	1298	1308	O
only	1309	1313	O
in	1314	1316	O
the	1317	1320	O
fat	1321	1324	B-Tissue
assay	1325	1330	O
.	1330	1331	O

CONCLUSION	1332	1342	O
:	1342	1343	O
This	1344	1348	O
angiogenesis	1349	1361	O
assay	1362	1367	O
based	1368	1373	O
on	1374	1376	O
human	1377	1382	B-Organism
fat	1383	1386	B-Tissue
tissue	1387	1393	I-Tissue
uses	1394	1398	O
three	1399	1404	O
-	1404	1405	O
dimensionally	1405	1418	O
intact	1419	1425	O
human	1426	1431	B-Organism
tissue	1432	1438	B-Tissue
.	1438	1439	O

The	1440	1443	O
vessels	1444	1451	B-Multi-tissue_structure
are	1452	1455	O
derived	1456	1463	O
from	1464	1468	O
quiescient	1469	1479	B-Multi-tissue_structure
vessels	1480	1487	I-Multi-tissue_structure
within	1488	1494	O
the	1495	1498	O
fat	1499	1502	B-Tissue
.	1502	1503	O

These	1504	1509	O
properties	1510	1520	O
allow	1521	1526	O
the	1527	1530	O
angiogenic	1531	1541	O
switch	1542	1548	O
to	1549	1551	O
be	1552	1554	O
evaluated	1555	1564	O
in	1565	1567	O
an	1568	1570	O
in	1571	1573	O
vitro	1574	1579	O
setting	1580	1587	O
.	1587	1588	O

The	1589	1592	O
angiogenic	1593	1603	O
response	1604	1612	O
of	1613	1615	O
fat	1616	1619	B-Tissue
tissue	1620	1626	I-Tissue
is	1627	1629	O
not	1630	1633	O
identical	1634	1643	O
to	1644	1646	O
placental	1647	1656	B-Tissue
tissue	1657	1663	I-Tissue
.	1663	1664	O

This	1665	1669	O
assay	1670	1675	O
allows	1676	1682	O
exploration	1683	1694	O
of	1695	1697	O
angiogenesis	1698	1710	O
in	1711	1713	O
fat	1714	1717	B-Tissue
tissue	1718	1724	I-Tissue
.	1724	1725	O

